At the conclusion of this activity, learners should be able to:

• Summarize changes in neuromuscular disease diagnosis that have impacted the practice of neuromuscular pathology

• Outline how genetic variants are classified as benign, pathogenic, or variants of uncertain significance

• Identify the more common neuromuscular genes showing variants of uncertain significance

• Compare and contrast tissue analysis modalities used in advanced muscle biopsy diagnosis